The former tennis player, 56, looked smitten as he showcased his political risk manager wife, 33, at Restaurant Borchardt.

Boris Becker's ex-wife Lilly has won the German version of I'm A Celebrity... Get Me Out Of Here! after stealing the hearts of the nation. The former Wimbledon tennis star, 57, has endured a ...

Lilly: "Everything was stressful. That's why, when you're in a relationship, it's better to keep it private!" And how did Boris Becker end up in prison? "Lilly: "I have no idea. I really don't.

The reason: Sam Dylan has dropped out of all the jungle trials so far. Lilly Becker doesn't like this at all, even though she has already been through a lot in her life. With her ex, for example.

If Eli Lilly has its way, this may be the future of obesity care. Eli Lilly makes some of the most powerful weight-loss drugs in the world. The company has pivoted dramatically over the past ...

Lily Allen is sharing details surrounding a recent visit to a treatment center. The singer discussed the visit on the latest episode of her BBC podcast “Miss Me?” with her cohost Miquita ...

Eli Lilly's small pop was due to the latest developments in the lab reported by Novo Nordisk (NYSE: NVO), which, like the U.S. company, is doing brisk business with a weight loss drug: Wegovy ...

Eli Lilly is experiencing explosive growth thanks to its diabetes and obesity treatments. Beyond weight loss, the company is quietly building a fast-growing oncology business. This is an enormous ...

Boris Becker has spoken openly about how his injuries have impacted his ability to be a “physical person”. The former tennis star, 57, sustained a number of injuries throughout his 16-year career, and ...

In a report released today, Terence Flynn from Morgan Stanley reiterated a Buy rating on Eli Lilly & Co (LLY – Research Report), with a price target of $1,146.00. The company’s shares closed ...

OnlyFans model Lily Phillips is facing some consequences after sleeping with 101 men in one day. “Yah, I’m banned off Airbnb,” Phillips, 23, claimed on the Wednesday, January 22, episode of ...

Eli Lilly LLY-N on Thursday suggested that demand for its popular diabetes and weight-loss treatments was not a concern, easing investor agitation about signs of weakness in sales of the drugs.